These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000984-81 A PHASE III PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, TOLERANCE AND EFFICACY STUDY OF RSD1235 IN SUBJECTS WITH ATRIAL FIBRILLATION OR ATRIAL FLUTTER 2005-07-30 due-trials
Listed as ongoing, but also has a completion date and reported results 2005-004195-20 A Phase 3, Multi-Center, Open Label Safety Study of RSD1235 in Subjects with Atrial Fibrillation. 2007-01-03 bad-data
Listed as ongoing, but also has a completion date 2005-004713-15 A Pilot Phase II, Randomised, Double-blind, Placebo-controlled, Multi-centred Safety, Tolerability and Preliminary Efficacy Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter... 2006-08-17 bad-data
Listed as ongoing, but also has a completion date 2006-005072-40 Vernakalant (oral) Prevention of Atrial Fbrillation Recurrence Post-Conversion Study 2008-07-04 bad-data
Listed as ongoing, but also has a completion date 2007-005625-29 A Phase III Prospective, Randomized, Double-Blind, Active-Controlled, Multi-Center, Superiority Study of Vernakalant Injection versus Amiodarone in Subjects with Recent Onset Atrial Fibrillation 2009-11-23 bad-data
Not reported 2010-018374-20 A Phase 3b Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Vernakalant Hydrochloride Injection in Patients with Recent Onset Symptomatic Atria... 2012-02-20 due-trials